| Literature DB >> 28471269 |
Jean-François Augusto1,2,3, Caroline Poli2, Céline Beauvillain2,4,3, Jean-François Subra1,2,3, Sebastien Jaillon5,6, Gilles Renier4, Alain Chevailler2,4,3, Xavier Puéchal7, Yves Delneste2,4,3, Pascale Jeannin2,4,3.
Abstract
Pentraxins are soluble pattern recognition molecules implicated not only in the opsonization and removal of microorganisms but also in the clearance of modified self (i.e., dying cells). Pentraxins can be classified into short pentraxins (C-reactive protein and serum amyloid-P component) and long pentraxins with pentraxin-3 (PTX3), the prototypic one of the latter. Pentraxins are involved in various physiological or pathophysiological processes such as inflammation and autoimmunity. A breakdown in immune tolerance to pentraxins has been reported in various autoimmune diseases. In the present review, we analyzed the current knowledge concerning anti-pentraxin antibodies, with a special focus on anti-PTX3 autoantibodies.Entities:
Keywords: Pentraxins; anti-pentraxin autoantibodies; autoimmune diseases; biomarkers; pentraxin-3
Mesh:
Substances:
Year: 2017 PMID: 28471269 DOI: 10.1080/08830185.2017.1284210
Source DB: PubMed Journal: Int Rev Immunol ISSN: 0883-0185 Impact factor: 5.311